CME Forum: Optimizing Outcomes in Iron Deficiency Anemia

Adaptive Approaches for the Ob-Gyn

Virtual Event | Oct 8, 2020

A CE Concepts Event

October 8, 7:30 p.m. ET

Iron deficiency anemia is a far-reaching condition of immense clinical impact in women’s health, with implications ranging from the global, epidemiological scale, to individual ob-gyn practices, and most importantly, to individual patients. As such, this educational initiative is designed to address the myriad challenges of iron deficiency anemia (IDA) in women’s health using a dynamic, multifaceted approach targeted to ob-gyns. Given their role as frontline clinicians with expertise across a multiplicity of women’s health conditions, ob-gyns are optimally positioned within the healthcare team to ensure the provision of safe, effective, and evidence-based treatment approaches for female patients with IDA. This initiative will provide a review of the epidemiology of IDA, including obstetrical morbidity and mortality implications, as well as equip ob-gyns with the tools they need to identify patients at high risk for IDA within their practice and properly prevent, diagnose, and treat IDA in those patients. Abnormal uterine bleeding (AUB) will be emphasized as a preeminent cause of IDA in women, and attendees will be given strategies they can employ to overcome the harmful cultural stigmas surrounding AUB. And lastly, using a case-based approach, this activity will evaluate currently-available IV and oral iron supplementation modalities, with a focus on tailored treatment strategies for patient’s refractory to oral iron therapy.

Supported by an independent educational grant from American Regent

Lee P. Shulman, MD

The Anna Ross Lapham Professor in Obstetrics and Gynecology
Feinberg School of Medicine of Northwestern University
Adjunct Professor of Pharmaceutical Science
University of Illinois College of Pharmacy
Chicago, Illinois